Works matching IS 0741238X AND DT 2024 AND VI 41 AND IP 4
Results: 34
Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1698, doi. 10.1007/s12325-024-02819-8
- By:
- Publication type:
- Article
Left Atrial Strain Insights in Atrial Fibrillation and the Interplay with Metabolic Syndrome.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1685, doi. 10.1007/s12325-024-02815-y
- By:
- Publication type:
- Article
An Update on Stiripentol Mechanisms of Action: A Narrative Review.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1351, doi. 10.1007/s12325-024-02813-0
- By:
- Publication type:
- Article
Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1672, doi. 10.1007/s12325-024-02812-1
- By:
- Publication type:
- Article
Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1728, doi. 10.1007/s12325-024-02811-2
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Sintilimab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: A Societal Perspective.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1436, doi. 10.1007/s12325-024-02808-x
- By:
- Publication type:
- Article
Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1621, doi. 10.1007/s12325-024-02806-z
- By:
- Publication type:
- Article
Correction to: Association of Patient Satisfaction with Cataract Grading in Five Types of Multifocal IOLs.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Exploring Perceptions of Biologic Therapies: A Qualitative Study Among Canadians Living with Severe Asthma.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1401, doi. 10.1007/s12325-024-02803-2
- By:
- Publication type:
- Article
Assessing Itch Severity: Content Validity and Psychometric Properties of a Patient-Reported Pruritus Numeric Rating Scale in Atopic Dermatitis.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1512, doi. 10.1007/s12325-024-02802-3
- By:
- Publication type:
- Article
Evolving Role of Viltolarsen for Treatment of Duchenne Muscular Dystrophy.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1338, doi. 10.1007/s12325-024-02801-4
- By:
- Publication type:
- Article
Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1606, doi. 10.1007/s12325-024-02800-5
- By:
- Publication type:
- Article
Respiratory Syncytial Virus (RSV) Burden in Infants in the Kingdom of Saudi Arabia and the Impact of All-Infant RSV Protection: A Modeling Study.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1419, doi. 10.1007/s12325-024-02798-w
- By:
- Publication type:
- Article
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1576, doi. 10.1007/s12325-024-02797-x
- By:
- Publication type:
- Article
Exposure–Response Efficacy Modeling to Support Trofinetide Dosing in Individuals with Rett Syndrome.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1462, doi. 10.1007/s12325-024-02796-y
- By:
- Publication type:
- Article
Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1746, doi. 10.1007/s12325-024-02795-z
- By:
- Publication type:
- Article
Patient and Clinician Perspectives: To Create a Better Future for Chronic Kidney Disease, We Need to Talk About Our Kidneys.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1318, doi. 10.1007/s12325-024-02794-0
- By:
- Publication type:
- Article
Development of a Conceptual Model for the Patient Experience of Immunoglobulin A Nephropathy (IgAN): A Qualitative Literature Review.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1325, doi. 10.1007/s12325-024-02793-1
- By:
- Publication type:
- Article
Application of Northern Goshawk Back-Propagation Artificial Neural Network in the Prediction of Monohydroxycarbazepine Concentration in Patients with Epilepsy.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1450, doi. 10.1007/s12325-024-02792-2
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1385, doi. 10.1007/s12325-024-02791-3
- By:
- Publication type:
- Article
Incidence and Costs of Clinically Significant Events with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1711, doi. 10.1007/s12325-024-02790-4
- By:
- Publication type:
- Article
A Response to: Letter to the Editor Regarding "Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China".
- Published in:
- 2024
- By:
- Publication type:
- Letter
7-Year Efficacy and Safety of iStent inject Trabecular Micro-Bypass in Combined and Standalone Usage.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1481, doi. 10.1007/s12325-024-02788-y
- By:
- Publication type:
- Article
Letter to the Editor Regarding "Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China".
- Published in:
- 2024
- By:
- Publication type:
- Letter
Lutein and Zeaxanthin Supplementation Improves Dynamic Visual and Cognitive Performance in Children: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1496, doi. 10.1007/s12325-024-02785-1
- By:
- Publication type:
- Article
Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH).
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1652, doi. 10.1007/s12325-024-02784-2
- By:
- Publication type:
- Article
Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1305, doi. 10.1007/s12325-024-02782-4
- By:
- Publication type:
- Article
Contraceptive Recommendations for Women with Immune-Mediated Inflammatory Diseases: A Delphi Consensus.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1372, doi. 10.1007/s12325-023-02779-5
- By:
- Publication type:
- Article
Correction to: Treatment-Related Cognitive Impairment in Patients with Prostate Cancer: Patients' Real-World Insights for Optimizing Outcomes.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1637, doi. 10.1007/s12325-023-02771-z
- By:
- Publication type:
- Article
Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1594, doi. 10.1007/s12325-023-02759-9
- By:
- Publication type:
- Article
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1553, doi. 10.1007/s12325-023-02728-2
- By:
- Publication type:
- Article
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1526, doi. 10.1007/s12325-023-02727-3
- By:
- Publication type:
- Article
Correction to: Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice